Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antiestrogens in the treatment of breast cancer.

× No keyword cloud information.

16 in total

Review 1. Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors: P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal: Clin Pharmacokinet Date: 1992-05 Impact factor: 6.447

Review 2. Toremifene in postmenopausal breast cancer. Efficacy, safety and cost.

Authors: J U Mäenpää; S L Ala-Fossi
Journal: Drugs Aging Date: 1997-10 Impact factor: 3.923

Review 3. Long-term adjuvant tamoxifen therapy for breast cancer.

Authors: V C Jordan
Journal: Breast Cancer Res Treat Date: 1990-05 Impact factor: 4.872

Review 4. [Current status in the treatment of breast cancer. I. Endocrine management--change of concepts and outlook for the future (author's transl)].

Authors: U Jehn; H Sauer; W Wilmanns
Journal: Klin Wochenschr Date: 1979-09-17

5. Effects of anti-estrogens on bone in castrated and intact female rats.

Authors: V C Jordan; E Phelps; J U Lindgren
Journal: Breast Cancer Res Treat Date: 1987-10 Impact factor: 4.872

6. Update in cancer chemotherapy: general considerations and breast cancer, Part I.

Authors: J C Wright
Journal: J Natl Med Assoc Date: 1985-08 Impact factor: 1.798

7. Interaction of [3H] estradiol - and [3H] monohydroxytamoxifen-estrogen receptor complexes with a monoclonal antibody.

Authors: A C Tate; E R DeSombre; G L Greene; E V Jensen; V C Jordan
Journal: Breast Cancer Res Treat Date: 1983 Impact factor: 4.872

8. Effect of toremifene on the growth, hormone receptors and insulin-like growth factor-1 of hormone-dependent MCF-7 tumors in athymic mice.

Authors: Y Iino; Y Takai; T Ando; N Sugamata; M Maemura; T Takeo; S Ohwada; Y Morishita
Journal: Cancer Chemother Pharmacol Date: 1993 Impact factor: 3.333

Review 9. Physiologic effects of steroid hormones and postmenopausal hormone replacement on the female breast and breast cancer risk.

Authors: I A Mustafa; K I Bland
Journal: Ann Surg Date: 1998-11 Impact factor: 12.969

Review 10. Tamoxifen as adjuvant therapy in breast cancer. Current status.

Authors: P N Plowman
Journal: Drugs Date: 1993-11 Impact factor: 9.546